{"name":"Immusoft","permalink":"immusoft","crunchbase_url":"http://www.crunchbase.com/company/immusoft","homepage_url":"http://immusoft.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@immusoft.com","phone_number":"","description":"","created_at":"Mon Apr 23 02:35:37 UTC 2012","updated_at":"Mon Apr 23 02:35:36 UTC 2012","overview":"<p>Immusoft is a Seattle-based biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP™) technology were developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft.</p>","image":null,"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Matthew","last_name":"Scholz","permalink":"matthew-scholz","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$350k","funding_rounds":[{"round_code":"grant","source_url":"http://www.finsmes.com/2012/04/immusoft-receives-350k-grant.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Immusoft Receives up to $350K Grant","raised_amount":350000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":21,"investments":[{"company":{"name":"Thiel Foundation","permalink":"thiel-foundation","image":null},"financial_org":null,"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"","address2":"","zip_code":"","city":"Seattle","state_code":"WA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}